Even among patients with similar tumor morphology characteristics (e.g., tumor size and tumor number) and comparable tumor biological markers (e.g., carcinoembryonic antigen, abbreviated as CEA) or within the same TNM stage, there remains significant diversity in outcomes following ICC resection [6, 7]. The gene discussed is CEACAM5; the disease is intrahepatic cholangiocarcinoma.